Palo Alto Investors’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $17.4M | Sell |
|
|||||
|
2021
Q1 | $36M | Sell |
|
|||||
|
2020
Q4 | $78.7M | Buy |
|
|||||
|
2020
Q3 | $52.4M | Buy |
|
|||||
|
2020
Q2 | $49.9M | Sell |
|
|||||
|
2020
Q1 | $57.7M | Sell |
|
|||||
|
2019
Q4 | $95M | Sell |
|
|||||
|
2019
Q3 | $93.8M | Sell |
|
|||||
|
2019
Q2 | $134M | Sell |
|
|||||
|
2019
Q1 | $166M | Buy |
|
|||||
|
2018
Q4 | $117M | Buy |
|
|||||
|
2018
Q3 | $167M | Buy |
|
|||||
|
2018
Q2 | $147M | Buy |
|
|||||
|
2018
Q1 | $127M | Buy |
|
|||||
|
2017
Q4 | $134M | Buy |
|
|||||
|
2017
Q3 | $152M | Buy |
|
|||||
|
2017
Q2 | $125M | Buy |
|
|||||
|
2017
Q1 | $125M | Buy |
|
|||||
|
2016
Q4 | $87.3M | Buy |
|
|||||
|
2016
Q3 | $68.8M | Buy |
|
|||||
|
2016
Q2 | $39.6M | Buy |
|